Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Plicamycin MeSH Descriptor Data 2025


MeSH Heading
Plicamycin
Tree Number(s)
D02.455.426.559.847.562.050.650
D04.615.562.050.650
D09.408.051.059.650
Unique ID
D008926
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008926
Scope Note
A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies.
Entry Term(s)
Aureolic Acid
Mithramycin
Mitramycin
Pharm Action
Antibiotics, Antineoplastic
Fluorescent Dyes
Protein Synthesis Inhibitors
Nucleic Acid Synthesis Inhibitors
Calcium-Regulating Hormones and Agents
Registry Numbers
NIJ123W41V
Related Numbers
18378-89-7
CAS Type 1 Name
Mithramycin
NLM Classification #
QV 269
Previous Indexing
Antibiotics, Antineoplastic (1967-1970)
Public MeSH Note
93; was MITHRAMYCIN 1973-92
Online Note
use PLICAMYCIN to search MITHRAMYCIN 1971-92 (as Prov 1971-72)
History Note
93; was MITHRAMYCIN 1971-92 (Prov 1971-72)
Date Established
1973/01/01
Date of Entry
1999/01/01
Revision Date
2018/05/22
Plicamycin Preferred
page delivered in 0.146s